Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA

Watchlist Manager
Sun Pharmaceutical Industries Ltd Logo
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Watchlist
Price: 1 795.3 INR 0.86% Market Closed
Market Cap: 4.3T INR
Have any thoughts about
Sun Pharmaceutical Industries Ltd?
Write Note

Sun Pharmaceutical Industries Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sun Pharmaceutical Industries Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Other Operating Expenses
-â‚ą163.6B
CAGR 3-Years
-17%
CAGR 5-Years
-11%
CAGR 10-Years
-11%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Other Operating Expenses
-â‚ą65.5B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
-9%
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Other Operating Expenses
-â‚ą53B
CAGR 3-Years
-10%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Other Operating Expenses
-â‚ą28.1B
CAGR 3-Years
-13%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
M
Mankind Pharma Ltd
NSE:MANKIND
Other Operating Expenses
-â‚ą10.8B
CAGR 3-Years
-178%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sun Pharmaceutical Industries Ltd
Glance View

Market Cap
4.3T INR
Industry
Pharmaceuticals

Sun Pharmaceutical Industries Ltd. is a leading global pharmaceutical company based in India, renowned for its commitment to producing high-quality generic and specialty medicines. Founded in 1983, Sun Pharma has evolved into one of the largest pharmaceutical companies in India and the fifth largest globally in the generic market. With a robust portfolio that encompasses various therapeutic areas, including cardiology, psychiatry, neurology, and oncology, the company has built a solid reputation for innovation and reliability. A strong emphasis on research and development drives Sun Pharma’s growth, helping it to continuously expand its product offerings and tap into new markets, as evidenced by its strategic acquisitions and partnerships over the years. For investors, Sun Pharmaceutical presents a compelling opportunity, underpinned by its solid financial performance and a forward-looking strategic vision. The company's extensive presence in over 150 countries combined with a diverse portfolio fuels its competitive edge in the global pharmaceutical landscape. With a solid track record of profitability and a commitment to enhancing shareholder value, Sun Pharma is well-positioned to capture growth in emerging markets and capitalize on advancements in biologics and complex generics. Moreover, the company’s focus on sustainability and ethical practices resonates in an increasingly socially conscious investment environment, making it an appealing prospect for investors looking to diversify their portfolios while supporting a responsible industry leader.

SUNPHARMA Intrinsic Value
1 046.73 INR
Overvaluation 42%
Intrinsic Value
Price

See Also

What is Sun Pharmaceutical Industries Ltd's Other Operating Expenses?
Other Operating Expenses
-163.6B INR

Based on the financial report for Sep 30, 2024, Sun Pharmaceutical Industries Ltd's Other Operating Expenses amounts to -163.6B INR.

What is Sun Pharmaceutical Industries Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
-11%

Over the last year, the Other Operating Expenses growth was -14%. The average annual Other Operating Expenses growth rates for Sun Pharmaceutical Industries Ltd have been -17% over the past three years , -11% over the past five years , and -11% over the past ten years .

Back to Top